Conversion from Sandimmune to Neoral in renal allograft recipients
10.1016/S0955-470X(99)80002-0
Saved in:
Main Author: | Vathsala, A |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
Elsevier BV
2022
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229616 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Safety and efficacy of conversion from once daily Sandimmune to twice daily Neoral cyclosporine in renal allograft recipients
by: Vathsala, A, et al.
Published: (2022) -
Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients
by: Arvind, C, et al.
Published: (2022) -
Spectrum of malignancies in Asian renal allograft recipients
by: Zinna, S, et al.
Published: (2022) -
Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression
by: Lou, HX, et al.
Published: (2022) -
Conversion from calcinuerin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24 month efficacy results from the CONVERT Trial
by: VATHSALA ANANTHARAMAN
Published: (2022)